Ledipasvir and Rosuvastatin: Drug Interaction Guide

Quick answer: This is a major interaction — avoid combining Ledipasvir and Rosuvastatin unless specifically directed by your doctor.

Interaction severity: Major — avoid combination

How Ledipasvir interacts with Rosuvastatin

Ledipasvir inhibits OATP1B1 and BCRP transporters that mediate rosuvastatin hepatic uptake and intestinal efflux, increasing rosuvastatin exposure 5-fold and myopathy risk.

What you should do

Limit rosuvastatin to 10 mg daily during ledipasvir therapy or switch to pravastatin temporarily.

Key facts

Severity

Major — avoid combination

Mechanism

Ledipasvir inhibits OATP1B1 and BCRP transporters that mediate rosuvastatin hepatic uptake and intestinal efflux, increa...

Action

Limit rosuvastatin to 10 mg daily during ledipasvir therapy or switch to pravastatin temporarily.

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Ledipasvir and Rosuvastatin together?

No — this combination should generally be avoided. Limit rosuvastatin to 10 mg daily during ledipasvir therapy or switch to pravastatin temporarily.

What is the severity of this interaction?

The interaction between Ledipasvir and Rosuvastatin is classified as Major — avoid combination. Ledipasvir inhibits OATP1B1 and BCRP transporters that mediate rosuvastatin hepatic uptake and intestinal efflux, increasing rosuvastatin exposure 5-fold and myopathy risk.

What should I do if I'm prescribed both?

Limit rosuvastatin to 10 mg daily during ledipasvir therapy or switch to pravastatin temporarily. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.